A drug to combat COVID: a webinar

August 22, 2021 by A J-Wire community service announcement
Read on for article
Australian Friends of Rambam as part of its Meet the Experts program are to host a live webinar in collaboration with the Australia-Israel Chamber of Commerce, Israel Embassy and Zionism Victoria to discuss MesenCure.

The Israeli Ministry of Health confirmed on Wednesday, August 11, that hospitals will begin treating critically ill COVID-19 patients with a new drug developed in Israel called “MesenCure“, manufactured by Bonus BioGroup. The decision was made after recent clinical trials with the experimental drug at Rambam, with good results: 14 out of 16 seriously ill COVID-19 patients treated with the drug were discharged from the hospital. More details about this are available here.
The registration link to the webinar which will be recorded is
Speakers will be
* Moderator: Dr. Adir Shiffman
* Professor Marylouise McLaws – Professor of Epidemiology, Hospital Infection and Infectious Diseases Control, UNSW
* Dr Michelle Ananda-Rajah MBBS (HONS), FRACP, PhD -An infectious diseases and general physician at Alfred Health
Date: Thursday, August 26
Time: 7pm


Speak Your Mind

Comments received without a full name will not be considered
Email addresses are NEVER published! All comments are moderated. J-Wire will publish considered comments by people who provide a real name and email address. Comments that are abusive, rude, defamatory or which contain offensive language will not be published

Got something to say about this?

This site uses Akismet to reduce spam. Learn how your comment data is processed.